neil harrison bander curriculum vitae curriculum vitae ...neil harrison bander curriculum vitae 1...

32
Neil Harrison Bander Curriculum Vitae 1 Curriculum Vitae Name: Neil Harrison Bander Place of Birth: Boston, Massachusetts Nationality: USA Office Address: Weill Medical College of Cornell University P.O. Box 23 525 East 68 th Street, New York, New York 10065 Licensed Physician: Year: 1974 Place of Issue: New York Board Certification: Year: 1983 Name: American Board of Urology Education: Johns Hopkins University 1969, B.A. (Biology) University of Connecticut Medical School 1974, M.D. Postdoctoral Training: 1974-77 Intern (1974-75); Junior Resident (1975-76); Resident (1976-77), General Surgery New York University-Bellevue Medical Center 1977-80 Resident, Urology (1977-78); Senior Resident, Urology (1978-79); Chief Resident, Urology (1979-80) University of Connecticut Medical Center 1980-83 NIH Immunobiology Research Fellow (Mentor: Lloyd J. Old, MD) Department of Human Tumor Immunology Sloan-Kettering Institute for Cancer Research 1982-83 F. C. Valentine Fellow (Mentor: Willet F Whitmore, Jr, MD) Urologic Oncology Service Memorial Sloan-Kettering Cancer Center

Upload: others

Post on 20-Jul-2020

30 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Neil Harrison Bander Curriculum Vitae Curriculum Vitae ...Neil Harrison Bander Curriculum Vitae 1 Curriculum Vitae Name: Neil Harrison Bander Place of Birth: Boston, Massachusetts

NeilHarrisonBander CurriculumVitae

1

CurriculumVitaeName: NeilHarrisonBanderPlaceofBirth: Boston,MassachusettsNationality: USAOfficeAddress: WeillMedicalCollegeofCornellUniversity

P.O.Box23 525East68thStreet,NewYork,NewYork10065

LicensedPhysician: Year: 1974 PlaceofIssue: NewYorkBoardCertification: Year: 1983 Name: AmericanBoardofUrologyEducation:

JohnsHopkinsUniversity 1969,B.A.(Biology)

UniversityofConnecticutMedicalSchool 1974,M.D.

PostdoctoralTraining:1974-77 Intern(1974-75);JuniorResident(1975-76);Resident(1976-77),

GeneralSurgeryNewYorkUniversity-BellevueMedicalCenter

1977-80 Resident,Urology(1977-78);SeniorResident,Urology(1978-79); ChiefResident,Urology(1979-80)

UniversityofConnecticutMedicalCenter1980-83 NIHImmunobiologyResearchFellow(Mentor:LloydJ.Old,MD)

DepartmentofHumanTumorImmunologySloan-KetteringInstituteforCancerResearch

1982-83 F.C.ValentineFellow(Mentor:WilletFWhitmore,Jr,MD)

UrologicOncologyServiceMemorialSloan-KetteringCancerCenter

Page 2: Neil Harrison Bander Curriculum Vitae Curriculum Vitae ...Neil Harrison Bander Curriculum Vitae 1 Curriculum Vitae Name: Neil Harrison Bander Place of Birth: Boston, Massachusetts

NeilHarrisonBander CurriculumVitae

2

PositionsandAppointments:Present BernardandJosephineChausProfessorofUrologicOncology,

DirectorofUrologicOncologyResearchWeillMedicalCollegeofCornellUniversity;

Member(Affiliate),DivisionofUrology,MemorialSloan-KetteringCancerCenterAttendingSurgeon,DivisionofUrology,MemorialHospital

1992-1999 AssistantMember,LudwigInstituteforCancerResearch,

MemorialSloan-KetteringCancerCenterScientificandMedicalSocieties: Fellow,AmericanCollegeofSurgery AmericanUrologicalAssociation AssociationforAcademicSurgery SocietyofUrologicOncology AmericanSocietyofClinicalOncology AmericanAssociationofCancerResearch CancerandLeukemiaGroupB(CALGB),GUCommittee,1989-94

OrganizingCommittee,IXthInternationalConferenceonMonoclonalAntibodyImmunoconjugates,1993-94Chair,MedicalResearchCommittee,NewYorkSection,American UrologicalAssociation,1994-95

Page 3: Neil Harrison Bander Curriculum Vitae Curriculum Vitae ...Neil Harrison Bander Curriculum Vitae 1 Curriculum Vitae Name: Neil Harrison Bander Place of Birth: Boston, Massachusetts

NeilHarrisonBander CurriculumVitae

3

HonorsandAwards:1969-70 AmericanCancerSocietyPre-doctoralResearchFellowship, Dana-FarberCancerCenter/HarvardMedicalSchool(Mentor:SidneyFarber,

M.D.)1973-74 MosbyScholarshipAward,UniversityofConnecticutMedicalSchool1980-83 National Institutes of Health Immunobiology Fellowship, Memorial Sloan-

KetteringCancerCenter(Mentor:LloydJ.Old,M.D.)1982-83 New York Academy of Medicine, Ferdinand C. Valentine Fellow in Urology

(Mentor:WilletF.Whitmore,Jr.,M.D.,MemorialSloan-KetteringCancerCenter1983 SocietyofSurgicalOncologyEwingResearchAward1989 Deutsche Gesellschaft fur Urologie (German Urological Association) Prize for

ExperimentalResearch1993-02 ProstateCancerFoundationResearchAwards(foreachyear)

2009 RoyalCollegeofSurgeons(London)Cutler’sSurgicalPrizeforInnovation

EditorialBoards:2004- EditorialBoard,TheProstate2010- EditorialBoard,ClinicalGenitourinaryCancer

AdvisoryBoards:1990-2001 MedicalAdvisoryBoard,NationalKidneyCancerAssociation1995- BZLBiologics,Inc.,ScientificAdvisoryBoard

1997-1999 Prostagen,Inc.,ScientificAdvisoryBoard

2002 ClevelandClinicUrology,SpecializedProgramofResearch

Excellence(SPORE),ExternalAdvisoryBoard

2002-2003 AdvisoryBoard,USTOO(NY)

Page 4: Neil Harrison Bander Curriculum Vitae Curriculum Vitae ...Neil Harrison Bander Curriculum Vitae 1 Curriculum Vitae Name: Neil Harrison Bander Place of Birth: Boston, Massachusetts

NeilHarrisonBander CurriculumVitae

4

2002 UrologicOncologyBranch,NationalCancerInstitute,External

AdvisoryBoard

1995-2005 KidneyCancerAssociation,MedicalAdvisoryBoard

2004-2008Agensys,Inc.,MedicalAdvisoryBoard(Chair:OwenWitte,PhD)

2007- BINDBiosciences,Inc.,ScientificAdvisoryBoard(Chair:R.Langer,PhD)

2008 AdvisoryBoard,BristolMyers-AcademicUrologists

2009 AdvisoryBoard,CancerSymposiumPlanningCommitteeforHunter CollegeGeneCenterandClinicalTranslationalScienceCenterSymposium2009 EndoPharmaceuticals,ScientificAdvisoryBoard

2010 MedicalAdvisoryBoard,CentocorOrthoBiotech,Inc.

2012- ADCTherapeutics,sarl,ScientificAdvisoryBoard(Chairman)

2014-2015 AvidityNanomedicines,LLCScientificAdvisoryBoard(co-Chairs:F.McCormick,PhD,M.Davis,PhD)

OtherActivities:1988 Member, Cancer Clinical Investigation Review Committee (CCIRC)-Ad Hoc

Committee on Urologic Oncology Cooperative Groups, National Institutes ofHealth

1988 SiteVisitCommittee,NationalCancerInstitute1992 VisitingProfessor,JapaneseUrologicalAssociation1994-2003 CancerCare&ResearchCommittee,NewYorkHospital-CornellMedical

Center1996-1998 HumanGeneticsandGeneTherapyWorkingGroup,NewYorkHospital-Cornell

MedicalCenter1996,1997 Review Committee, Cancer Research Institute’s Prostate Cancer Clinical Trials

Program1995,1997 Reviewer,OhioCancerResearchCenterGrants

Page 5: Neil Harrison Bander Curriculum Vitae Curriculum Vitae ...Neil Harrison Bander Curriculum Vitae 1 Curriculum Vitae Name: Neil Harrison Bander Place of Birth: Boston, Massachusetts

NeilHarrisonBander CurriculumVitae

5

1996,2006 ProstateCancerFoundationGrantReviewCommittee1998,1999 Reviewer,DepartmentofDefense-ProstateCancerResearchProgram

1997 Member,NationalCancerInstituteUrologicOncologyBranch’sTenure TrackUrologicSurgeonSearchCommittee1999 ConsultantinUrology/UrologicalOncology,StrangCancerPrevention Center

2003 VisitingProfessor,SeminarsinClinicalResearch,RockefellerUniversity2003 VisitingProfessor,DepartmentofUrology,UCLASchoolofMedicine2003 VisitingProfessor,JohnsHopkins“CaP2003NewPerspectives”2003 VisitingProfessor,BaylorCollegeofMedicine,GUSeminarSeries2004-2009 IndependentDataSafetyMonitoringCommittee–Dendreon,Inc. 2005 VisitingProfessor,VIthEuropeanSymposiumoftheProteinSociety,

Barcelona,Spain 2005–2007 Member,InstitutionalReviewBoard,NewYork-PresbyterianHospital2006- Reviewer,USArmyMedicalResearchandMaterialCommand(USAMRMC)

FiscalYear2006(FY06)ProstateCancerResearchProgram(PCRP)IntegrationPanel.

2007-2011 WeillCornellMedicalCollegeCancerCenterInternalAdvisoryCommittee

Member

2007-2015RadioactiveDrugResearchCommittee

2008-2012Member,SearchCommittee,DirectorofResearch,UrologyDepartment 2009,2010, Reviewer,USArmyMedicalResearchandMaterialCommand2012 (USAMRMC),ProstateCancerProgram2011 Member,FacultyAdvisoryGroupforWCMCWebCalendarofEvents2011-2014 WCMC-PfizerCentersofTechnologyInnovationJointSteeringCommittee

Page 6: Neil Harrison Bander Curriculum Vitae Curriculum Vitae ...Neil Harrison Bander Curriculum Vitae 1 Curriculum Vitae Name: Neil Harrison Bander Place of Birth: Boston, Massachusetts

NeilHarrisonBander CurriculumVitae

6

2012-2015 Member,Weill-CornellDataSafetyMonitoringBoard2012 WCMCAdhocAdvisorySubcommitteeonTenure2013,2014 Chairman,ReviewPanel,USArmyMedicalResearchandMaterialCommand (USAMRMC),ProstateCancerProgram2013- InternalAdvisoryBoard,WCMCProstateSPORE2014-Member,CancerImmunotherapyGuidelines–GenitourinaryMalignanciesTaskForce(CIG-GU):SocietyforImmunotherapyofCancer(SITC)2014-Member,CommitteeonPromotions,WCMC,DeptofUrology2016- Member,CommitteeofReview,WCMC

Page 7: Neil Harrison Bander Curriculum Vitae Curriculum Vitae ...Neil Harrison Bander Curriculum Vitae 1 Curriculum Vitae Name: Neil Harrison Bander Place of Birth: Boston, Massachusetts

NeilHarrisonBander CurriculumVitae

7

BIBLIOGRAPHY

1.ConroyMC,BanderNHandLepowIH:Effectofintradermalinjectionsintheratofpurifiedproteases fromStreptococcusandSerratiamarescens. ProcSocExpBiolMed1975;150:801-805.2. BanderNH: Comparisonofantigenexpressionofhumanrenalcancer invivoand invitro.Cancer1984;53:1235-1239.3. Cordon-CardoC,BanderNH,FradetY,FinstadCL,WhitmoreWFJr,LloydKO,OettgenHF,Melamed MR and Old LJ: Immunoanatomic dissection of the human urinary tract bymonoclonalantibodies.JHistochemCytochem1984;32:1035-1040.4.BanderNH,WeltS,HoughtonAN,LloydKO,GrandoR,YehS,WhitmoreWFJr,VaughanEDJr, Oettgen HF and Old LJ: Radionuclide imaging of human renal cancer with labeledmonoclonalantibodies.SurgForum1984;35:652-655.5. Bander NH: Renal cancer: A model system for the study of human neoplasia. In:Contributions in Oncology, Riethmuller G, Koprowski H, von Kleist S, (eds). S. Karger, Basel)1984.6. Finstad CL, Cordon-Cardo C, Bander NH, Whitmore WF Jr, Melamed MR and Old LJ:Specificity analysis of mousemonoclonal antibodies defining cell surface antigens of humanrenalcancer.ProcNatlAcadSciUSA1985;82:2955-2959.7. Bander NH, Cordon-Cardo C, Finstad CL, Whitmore WF Jr, Vaughan ED Jr, Oettgen HF,MelamedMRandOld,LJ:Immunohistologicdissectionofthehumankidneyusingmonoclonalantibodies.JUrol1985;133:502-505.8. Bander NH: Study of the normal human kidney and kidney cancer with monoclonalantibodies.UremiaInvest1985;8:263-273.9. Fleischmann J, HestonW, BauerW, Ratliff T,Bander NH and FairW: Human renal cellcarcinomaxenograftmorphology,growthandchemosensitivities.JUrol1985;134:570-574.10.BanderNH and Cordon-Cardo C: Monoclonal antibody definedmarkers of human renalcancer. In: MonoclonalAntibodiestoTumorMarkers,SellS,ReisfeldR,(eds).HumanaPress,Clifton,NJ,1985.11.RosenbergS,BanderNHandHerrH:Testistumors.In:CurrentTherapyinEndocrinology,KriegerD,BardinW,(eds).BCDecker,Philadelphia,PA1985.

Page 8: Neil Harrison Bander Curriculum Vitae Curriculum Vitae ...Neil Harrison Bander Curriculum Vitae 1 Curriculum Vitae Name: Neil Harrison Bander Place of Birth: Boston, Massachusetts

NeilHarrisonBander CurriculumVitae

8

12.Tolkoff-RubinNE,CosimiAB,DelmonicoFL,RussellPS,ThompsonRE,PiperDJ,HansenWP,BanderNH,FinstadCL,Cordon-CardoC,KlotzLH,OldandRubinRH:Diagnosisoftubularinjuryin renal transplantpatientsbyaurinaryassay foraproximal tubularantigen, theadenosine-deaminase-bindingprotein.Transplantation1986;41:593-597.13. Cordon-CardoC,LloydKO,FinstadCL,McGroartyME,ReuterVE,BanderNH,OldLJandMelamedMR: Immunoanatomic distribution of blood group antigens in the human urinarytract.Influenceofsecretorstatus.LabInvest1986;55:444-454.14. SternbergCN,YagodaA,BanderNH,WhitmoreWFJr,HuffmanJL,FleisherM,MelamedMR,FanucchiMP,HollanderPandVaughanEDJr:PhaseI/IItrialofintravesicalmethotrexateforsuperficialbladdertumors.CancerChemotherPharmacol1986;18:265-269.15.Tolkoff-RubinNE,CosimiAB,DelmonicoFL,RussellPS,ThompsonRE,PiperDJ,HansenWP,BanderNH, FinstadCL, Cordon-CardoC, Klotz LH,Old LJ andRubinRH: Monitoringof renalproximal tubular injury in transplantation with a monoclonal antibody-based assay for theadenosinedeaminase-bindingprotein.TransplantProc1986;18:716-718.16.BanderNH:Monoclonalantibodies.In:AmericanUrologicalAssociationUpdate,BallTPJr,NovickDE,(eds).AUAOfficeofEducation,Houston,TX1986.17.BanderNH:Monoclonalantibodiesandthediagnosisandtreatmentofbladdercancer.In:Bladder Cancer: Future Directions for Treatment, Yagoda A, (ed). JohnWiley& Sons, NY, NY1986.18. BanderNHandKlotzLH: Tumorimmunology: In: UrologicOncology,GrahamSJr,(ed).RavenPress,NY,NY1986.19. Cordon-Cardo C, Finstad CL, Bander NH, Old LJ and Melamed MR: Immunoanatomicdistributionofcytostructuralandtissue-associatedantigens inthehumanurinarytract. AmJPathol1987;126:269-284.20.Tolkoff-RubinNE,ThompsonRE,PiperDJ,HansenWP,BanderNH,Cordon-CardoC,FinstadCL, Klotz LH, Old LJ and Rubin RH: Diagnosis of renal proximal tubular injury by urinaryimmunoassayforaproximaltubularantigen,the adenosine deaminase-binding protein.NephrolDialysisTransplant1987;2:143-121. Kantor RRS,Bander NH, Finstad CL, Graf LH Jr, Lloyd KO, Old LJ and Albino AP: DNA-mediated gene transfer of a human cell surface 170-kilodalton glycoprotein. Evidence forassociationwithanendogenousmurineprotein.JBiolChem1987;262:15166-15171.22.CarterHB,AmbersonJB,BanderNH,BadalmentR,GorelickJ,VaughanEDJrandWhitmoreWFJr:Newerdiagnostictechniquesforbladdercancer.UrolClinN Amer 1987; 14(4):763-769.

Page 9: Neil Harrison Bander Curriculum Vitae Curriculum Vitae ...Neil Harrison Bander Curriculum Vitae 1 Curriculum Vitae Name: Neil Harrison Bander Place of Birth: Boston, Massachusetts

NeilHarrisonBander CurriculumVitae

9

23.BanderNH:Monoclonalantibodies:Stateoftheart.JUrol1987;137:603-612.24. Klotz LH and Bander NH: Monoclonal antibodies and urologic oncology: Antigenicexpressionongenitourinary tumors. In: GenitourinaryCancer,RatliffTL,CatalonaWJ, (eds).MartinusNijhoffPublishers,Boston,MA,1987.25. Weir EC, Insogna KL, Brownstein DG, Bander NH and Broadus AE: In vitro adenylatecyclase-stimulatingactivitypredictstheoccurrenceofhumoralhypercalcemiaofmalignancyinnudemice.JClinInvest1988;81(3):818-821.26. Bander NH: Continent urinary diversion in the treatment of bladder cancer. NewDevelopmentsinMedicine1988;2:65-81.27. ManginM,WebbAC,Dreyer BE, Posillico JT, Ikeda K,Weir EC, Stewart AF,BanderNH,Barton DE, Francke U and Broadus AE: Identification of a complementary DNA encoding aparathyroidhormone-likepeptidefromahuman tumor associated with humoralhypercalcemiaofmalignancy.ProcNatlAcadSciUSA1988;85:597-601.28. Sternberg C, Yagoda A, Scher H,Watson R, Herr H,MorseM, Sogani P, Vaughan ED Jr,BanderNH,WeiselbergL,GellerN,HollanderP,LippermanR,FairWR andWhitmoreWF Jr:M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cellcarcinomaoftheurothelium.JUrol1988;139:461-469.29.IkedaK,ManginM,DreyerB,WebbA,PosillicoJ,StewartA,BanderNH,WeirE,InsognaKandBroadusAE: Identificationof transcriptsencodingaparathyroidhormone-likepeptide inmessenger RNAs from a variety of human and animal tumors associated with humoralhypercalcemiaofmalignancy.JClinInvest1988;81:2010-2014.30.SternbergCN,YagodaA,ScherHI,WatsonRC,HerrHW,MorseMJ,SoganiPC,VaughanEDJr,Bander NH, Geller N, FairWR andWhitmoreWF Jr: Chemotherapeuticmanagement ofinvasivebladdercarcinoma.EurUrol1988;14(suppl):19-20.31. BanderNH,FinstadCL,Cordon-CardoC,RamsawakRD,VaughanEDJr,WhitmoreWFJr,OettgenHF,MelamedMRandOld LJ: Analysis of amousemonoclonal antibody that reactswith a specific region of the human proximal tubule and subsets of renal cell carcinomas.CancerRes1989;49:6774-6780.32.SternbergC,YagodaA,ScherHI,GellerN,HerrHW,MorseMJ,SoganiPC,VaughanEDJr,BanderNHetal.:M-VACforadvancedtransitionalcellcarcinomaoftheurothelium:efficacy,andpatternsofresponseandrelapse.Cancer1989;64:2448-2458.

Page 10: Neil Harrison Bander Curriculum Vitae Curriculum Vitae ...Neil Harrison Bander Curriculum Vitae 1 Curriculum Vitae Name: Neil Harrison Bander Place of Birth: Boston, Massachusetts

NeilHarrisonBander CurriculumVitae

10

33. Nanus DM, Ebrahaim SAD, Bander NH, Real FX, Pfeffer LM, Shapiro JR and Albino AP:Transformation of human kidney proximal tubule cells by ras-containing retroviruses.Implicationsfortumorprogression.JExpMed1989;169:953-972.34. WangJCL,WalleA,NovogrodskyA,SuthanthiranM,SilverRT,BanderNH,RubinALandStenzel KH: A phase II clinical trial of adoptive immunotherapy for advanced renal cellcarcinoma using mitogen-activated autologous leukocytes and continuous infusion ofinterleukin-2.JClinOncol1989;7:1885-1891.35. Yagoda A and Bander NH: Failure of cytotoxic chemotherapy, 1983-1988, and theemergingroleofmonoclonalantibodiesforrenalcancer.UrolInt1989;44:338-345.36.BanderNH:ed.Renalcellcarcinoma.In:SeminarsinUrology,vol7,no3,WBSaunders,Philadelphia,PA,1989.37.EbertTandBanderNH:Kidney-derivedcelllines.SeminarsinUrology1989;7:247-251.38.BanderNH:Monoclonalantibodiestorenalcancerantigens.SeminarsinUrology1989;7:264-270.39. Bander NH: Ureteral stent for nonrefluxing, continent urinary diversions reducescomplicationsandhospitalizationforpatients.Urol1990;35:64-67.40.NanusDM,MentleIR,MotzerRJ,BanderNHandAlbinoAP:Infrequentrasoncogenepointmutationsinrenalcellcarcinoma.JUrol1990;143:175-178.41. Nanus DM, Pfeffer LM,Bander NH, Bahri S and Albino AP: Anti-proliferative and anti-tumoreffectofalpha-interferon in renal carcinoma: correlation to theexpressionof kidneyassociateddifferentiationglycoprotein.CancerRes1990;50:4190-4194.42. Ebert T, Bander NH, Finstad CL, Ramsawak RD and Old LJ: Establishment andcharacterizationofrenalcancerandnormalkidneycelllines.CancerRes1990;50:5531-5536.43. RettigWJ,TricheTJandBanderNH: Somaticcellgeneticanalysisofhumancell surfaceantigens5.1H11andF35/9(gp45).Genomics1990;6:178-183.44. Libby DM, Bander NH, Altorki NK, Gold J, Pitts WR Jr and Frankel SS: Simultaneouspulmonaryandrenalmalignancy.Chest1990;98:153-156.45. KerrL,HuntcoonC,DonohueJ,LeibsonPJ,BanderNH,GhoseT,LunerSJ,VessellaRandMcKeanDJ: Heteroconjugateantibody-directedkillingof autologoushuman renal carcinomacellsininvitroactivatedlymphocytes.J Immunol1990;44:4060-4067.46.BanderNH:Monoclonalantibodiestorenalcancerantigens.EurUrol1990;18:10-12.

Page 11: Neil Harrison Bander Curriculum Vitae Curriculum Vitae ...Neil Harrison Bander Curriculum Vitae 1 Curriculum Vitae Name: Neil Harrison Bander Place of Birth: Boston, Massachusetts

NeilHarrisonBander CurriculumVitae

11

47.EbertTandBanderNH:Immunodiagnosisofrenalcancer.In:ImmunodiagnosisofCancer,MercerDW,HerbermanRB,(eds).MarcelDekker,NewYork,NY199048. Sheinfeld J, Cordon-Cardo C and Bander NH: Immunodiagnosis of bladder cancer. In:ImmunodiagnosisofCancer,MercerDW,HerbermanRB, (eds).MarcelDekker,NewYork,NY1990.49. Ebert T, Ackerman R and Bander NH: Biologische marker beim nierenzellkarzinom.Urologie1990;29:65-70.50.GulmiFAandBanderNH:Managingcarcinomainsituofthebladder.ContempUrol1990;1:45-52.51. BanderNH:InitialresultswithaslightlymodifiedKochpouch.Urol1991;37:100-105.52.GastlG,FinstadCL,GuariniA,BoslG,GilboaE,BanderNHandGansbacherB: Retroviralvector-mediatedlymphokinegenetransferintohumanrenalcancercells.CancerRes1992;52:6229-6236.53.BanderNH,GastlG,NanusDM,PfefferLM,FinstadCLandAlbinoAP:Anti-proliferativeandanti-tumoreffectofa-interferoninrenalcellcarcinoma: Correlationwiththeexpressionofakidneyassociateddifferentiationglycoprotein. In:BasicandClinicalResearchonRenalCellCarcinoma,StaehlerG,PomerS, (eds).Springer-Verlag,Heidelberg,Germany1992.54. Oosterwijk E, Bander NH, Divgi CR,Welt S,Wakka JC, Finn R, Carswell EA, Larson SM,Warnaar SO, Fleuren GJ, Oettgen HF andOld LJ: Antibody localization in human renal cellcarcinoma:AphaseIstudyofmonoclonalantibodyG250.JClinOncol1993;11:738-750.55.GastlG,PlanteM,FinstadCL,WongGY,FedericiMG,BanderNHandRubinSC:HighIL-6levels inascitic fluidcorrelatewithreactivethrombocytosis inpatientswithepithelialovariancancer.BritJHeamatol1993;83:433-441.56.GastlG,AbramsJS,NanusDM,OosterkampR,SilverJ,LiuF,ChenN,AlbinoAPandBanderNH:Interleukin-10productionbyhumancarcinomacelllinesanditsrelationshiptointerleukin-6expression.IntJCancer1993;55:96-101.57. NanusDM,EngelsteinD,GastlGA,GluckL,VidalMJ,MorrisonM,FinstadCL,BanderNHandAlbinoAP:Molecularcloningofthehumankidneydifferentiationantigengp160:humanaminopeptidaseA.ProcNatlAcadSciUSA1993; 90:7069-7073.58. Holt EH, Vasavada RC, Bander NH, Broadus AE and Philbrick WM: Region-specificmethylation of the parathyroid hormone-related peptide gene determines its expression inhumanrenalcarcinomacelllines.JBiolChem1993;268:20639-20645.

Page 12: Neil Harrison Bander Curriculum Vitae Curriculum Vitae ...Neil Harrison Bander Curriculum Vitae 1 Curriculum Vitae Name: Neil Harrison Bander Place of Birth: Boston, Massachusetts

NeilHarrisonBander CurriculumVitae

12

59.GastlG,BanderNH,FrickJ,HuberCandAulitzkyW:Immunotherapiedesmetastasiertennierenzellkarzinomas mit rekombinantem interferon-gamma. In: Immunotherapie in derUroonkologie, Rubben H, Goepel M, Schmitz-Drager B, (eds). Springer-Verlag, Heidelberg,Germany1993.

60. Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Li H, Latif F, Liu S, Chen F, Duh F-M,Lubensky I, Duan D-S R, Florence C, Pozzatti R,WaltherMM,BanderNH et al.: VHL tumorsuppressorgenemutationsinrenalcellcarcinomatumorigenesis.NatureGenet1994;7:85-90.61.BanderNH:Currentstatusofmonoclonalantibodiesforimagingandtherapyofprostatecancer.In:SeminarsinOncology,ScherH.,(ed).WBSaunders,NewYork,NY1994;21.62. BergerMF,Oosterwijk E,BanderNH, Divgi CR,Welt S,Wakka JC, FinnRD, Carswell EA,LarsonSM,WarnaarSO,vanFleurenG,OettgenHFandOldLJ:Antibodylocalizationinhumanrenalcellcarcinoma:AphaseIstudyof monoclonal antibody G250. In: Biology of RenalCellCarcinoma,BukowskiRM,FinkeJH,KleinEA,(eds).Springer-Verlag,NewYork,NY1995.63. BanderNH: Immunologyof renal cancer. In:ComprehensiveTextbookofGenitourinaryOncology, Vogelzang NJ, Scardino PT, Shipley WU, Coffey DS, (eds). Williams & Wilkins,Philadelphia,PA1995.64. KinouchiT,BanderNHandKotakeT: ReactivitiesofmousemonoclonalantibodyK2.7torenalcancersincomplement-dependentcytotoxicityandantibody dependent cell-mediatedcytotoxicity.JUrol1995;154:288-292.65.AoyagiT,BanderNH:Cytotoxicityofgalliumnitrateinvitrousingbladdercancercells.IntJUrol1995;2(5):288-294.66.GastlG,EbertT,FinstadCL,SheinfeldJ,GomahrA,AulitzkyWandBanderNH:MHC Class I and Class II expression in renal cell carcinoma and modulation by interferon-gamma.JUrol1996;155:361-367.67.MotzerRJ,BanderNHandNanusDM:Renalcellcarcinoma.NEnglJMed1996;335:865-875.68.ShemtovMMandBanderNH:Immunologicapproachestogenitourinarymalignancies.InCampbell’s Urology Update (Patrick C Walsh, Alan B Retik, Thomas A Stamey, E DarracottVaughanandAlanJWein,(eds)Philadelphia,PA.20,1996.69. McKiernanJM,ButtyanR,BanderNH,StifelmanMD,KatzAE,ChenM-W,OlssonCAandSawczuk IS: Expression of the tumor-associated geneMN; a potential biomarker for humanrenalcellcarcinoma.CancerRes1997;57:2362-2365.

Page 13: Neil Harrison Bander Curriculum Vitae Curriculum Vitae ...Neil Harrison Bander Curriculum Vitae 1 Curriculum Vitae Name: Neil Harrison Bander Place of Birth: Boston, Massachusetts

NeilHarrisonBander CurriculumVitae

13

70.SchmetterBS,HabichtKK,LammDL,MoralesA,BanderNH,GrossmanHB,HannaJrMG,Silberman SR and Butman BT: A multicenter trial evaluation of the Aura-Tek FDP test fordetectionandmonitoringofbladdercancer.JUrol1997;158:801-805.71.MotzerRJ,BanderNHandNanusDM:LettertotheEditor.NEnglJMed1997;336:810-811.72. Liu H, Moy P, Kim S, Xia Y, Rajasekaran A, Navarro V, Knudsen B and Bander NH:Monoclonalantibodiestotheextracellulardomainofprostatespecificmembraneantigenalsoreactwithtumorvascularendothelium.CancerRes1997;57:3629-3634.73.BanderNH,YaoD,LiuH,ChenY-T,SteinerM,ZuccaroWandMoyP:MHCClassIandIIexpressioninprostatecarcinomaandmodulationbyinterferon-alphaand-gamma.TheProstate1997;33:233-239.74. Oosterwijk E,BanderNH, Divgi CR,Welt S,Wakka JC, FinnRD, Carswell EA, Larson SM,Warnaar SO, Fleuren GJ, Oettgen HF, and Old LJ: Antibody localization in human renal cellcarcinoma: A phase I study of monoclonal antibody G250. Classic Papers and CurrentComments1997;2:331-344.75. BanderNH, Cordon-CardoC, Finstad CL,WhitmoreWF Jr., Vaughan ED Jr.,OettgenHF,MelamedM,andOldLJ:SummaryofImmunohistologicDissectionoftheHumanKidneyUsingMonoclonalAntibodies.SeminarsinUrolOncol1997;15(2):123-130.76.NanusDM,BogenriederT,PapandreouCN,FinstadCL,LeeA,VlamisV,MotzerRJ,BanderNH,AlbinoAP,andReuterVE:AminopeptidaseAexpressionandenzymaticactivityinprimaryhumanrenalcancers.IntJOncology1998;13(2):261-267.77.LiuH,RajasekaranA.K.,MoyP.,XiaY.,KimS.,NavarroV.,RahmatiR.,andBanderNH:ConstitutiveandAntibody-Induced InternalizationofProstateSpecificMembraneAntigen.CancerRes1998;58:4055-4060.78.DivgiC.R.,BanderNH,ScottA.M.,O’Donoghue,SgourosG,WeltS.,FinnR.D.,MorrisseyF.,CapitelliP.,WilliamsJ.M.,DelandD.,NakhreA.,OosterwijkE.,GulecS.,GrahamM.C.,LarsonS.M., Old L.J.: Phase I/II radioimmunotherapy trial with iodine-131 labeled monoclonalantibody(mAb)G250inmetastaticrenalcarcinoma.ClinCancerRes1998;4:2729-2739.79.PrewettM,RothmanM,WaksalH,FeldmanM,BanderNH,andHicklinD.J.:Mouse-human chimeric anti-epidermal growth factor receptor antibody C225 inhibits thegrowthofhumanrenalcellcarcinomaxenograftsinnudemice.ClinCancerRes1998;4:2957-2966.80.EbertT,AnastasiadisA,BanderNH:RenalCellCancerinHumanCellCultureJR.W.MastersandB.Palsson(eds).KluwerAcademicPublishers1999.

Page 14: Neil Harrison Bander Curriculum Vitae Curriculum Vitae ...Neil Harrison Bander Curriculum Vitae 1 Curriculum Vitae Name: Neil Harrison Bander Place of Birth: Boston, Massachusetts

NeilHarrisonBander CurriculumVitae

14

81.UzzoRG,RaymanP,KolenkoV,ClarkPE,BloomT,WardAM,MoltoL,TannenbaumC,WorfordLJ,BukowskiR,TubbsR,HsiED,Bander,NH,NovickAC,andFinkeJH:Mechanismsof apoptosis in T cells frompatientswith renal cell carcinoma. Clin Cancer Res1999;5:1219-1229.82.KolenkoV,UzzoRG,BukowskiR,BanderNH,NovickAC,FinkeJH:Deadordying:Necrosisvs.apoptosisincaspasedeficienthumanrenalcellcarcinoma.CancerRes,1999,59:2838-2842.83.ChangSS,ReuterVE,HestonWDW,BanderNH,GrauerLS,andGaudinPB: Fivedifferentanti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression intumor-associatedneovasculature.CancerRes1999;59:3192-3198.84.GongMC,LatoucheJB,KrauseA,HestonWDW,BanderNH&SadelainM.CancerpatientTcells genetically targeted to prostate-specific membrane antigen specifically lyse prostatecancer cells and release cytokines in response to prostate-specific membrane antigen.Neoplasia1999;1(2):123-127.85. Rajasekaran SA, BallWJ Jr,BanderNH., LiuH, Pardee JD, andRajasekarenAK: Reducedexpression ofβ-subunit of Na,K-ATPase in human clear-cell renal cell carcinoma. J Urology,1999;162:574-580.86.ShirakawaT,GardnerTA,KoS-C,BanderN,WooS,GotohA,KamidonoS,Chung LWK and Kao C: Cytotoxocity of adenoviral-mediated cytosine deaminase plus 5-fluorocytosinegenetherapyissuperiortothymidinekinaseplusacyclovirinahumanrenalcellcarcinomamodel.JUrology1999;162:949-954.87.ScanlanMJ,GordanJD,WilliamsonB,StockertE,BanderNH,JongeneelV,Gure AO, Jager D, Jager E, Knuth A, Chen YT andOld LJ: Antigens recognized by autologousantibodyinpatientswithrenal-cellcarcinoma.IntJCancer1999,83(4):456-464.88.ChangSS,BanderNH,HestonWDW:MonoclonalAntibodies:Willtheybecomeanintegralpartoftheevaluationandtreatmentofprostatecancer-focusonprostate-specificmembraneantigen.CurrentOpinionInUrology1999;9:391-395.89.BanderNH:Monoclonalantibodiesforimagingandtherapyofprostatecancer.KleinE(ed).ManagementofProstateCancer.HumanaPress,Totowa,NJ:1999.90.GongMC,ChangSS,SadelainM,BanderNH,HestonWDW:Prostate-specificmembraneantigen(PSMA)-specificmonoclonalantibodiesinthetreatmentofprostatecancer.CancerMetastasisRev1999;18:483-90.

Page 15: Neil Harrison Bander Curriculum Vitae Curriculum Vitae ...Neil Harrison Bander Curriculum Vitae 1 Curriculum Vitae Name: Neil Harrison Bander Place of Birth: Boston, Massachusetts

NeilHarrisonBander CurriculumVitae

15

91.McKiernanJM,ButtyanR,BanderNH,delaTailleA,StifelmanMD,EmanuelER,BagiellaE,RubinMA,KatzAE,OlssonCA,SawczukIS:ThedetectionofrenalcancercellsintheperipheralbloodviaanenhancedRT-PCRassayforMN/CA9.Cancer,1999;86(3):492-497.92.BanderNH:Monoclonalantibodiesinthediagnosisandtreatmentofrenalcancer.VogelzangNJetal (eds). ComprehensiveTextbookofGenitourinaryOncology,SecondEdition,LippincottWilliams&Wilkins,Philadelphia,PA,1999.93.OosterwijkE,DivgiCR,SteffensMSandBanderNH:Monoclonalantibodiesinadvanced renal cell carcinoma. Bukowski RM and Novick AC (eds). Renal Cell Carcinoma –MolecularBiology,Immunology,andClinicalManagement,HumanaPress,Totowa,NJ:2000.94 Smith-JonesPM,VallabahajosulaS,GoldsmithSJ,NavarroV,HunterCJ,BastidasDandBander NH: In vitro characterization of radiolabeledmonoclonal antibodies specific for theextracellulardomainofprostatespecificmembraneantigen. CancerRes,2000;60(18):5237-5243.95.McDevittMR,BarendswaardE,MaD,CurcioMJ,LaiL,SgourosG,BallangrudAM,YangW-H,FinnRD,GeerlingsMWJr,BrechbielMW,BanderNH,andScheinbergDA:AnAlpha-particleemittingantibody([213Bi]J591)forradioimmunologyofprostatecancer.CancerRes.2000;60:6095-6100.96. GongMC, Chang SS,Watt F,O’KeefeDS, BacichDJ,UchidaA,BanderNH, Reuter VE,GaudinPB,MolloyPL,SadelainM,HestonWD:Overviewofevolvingstrategies incorporatingprostate-specificmembraneantigenastargetfortherapy.MolUrol2000:4(3):217-222.97.delaTailleA;CaoY,SawczukIS,NozemuT,d’AgatiV,McKiernanJM,BagiellaE,ButtyanR,BurchardtM,OlssonCA,BanderN,KatzAE:Detectionofprostate-specificmembraneantigenexpressingcellsinbloodobtainedfromrenalcancerpatients:apotentialbiomarkerofvascularinvasion.CancerDetectPrev2000,24(6):2008-2014.98.RajasekaranSA,PalmerLG,BallWJJr,BanderNH,AlejandroPeraltaSolerandRajasekaranAK:Na,K-ATPaseβ-subunit is required for epithelial polarization, suppressionof invasionandcellmotility.MolBiolCell2001;12:279-295.99. Goldsmith SJ,BanderNH: Prostate cancer:MonoclonalAntibody Therapy. Khalkhali I,MaublantJC,GoldsmithSJ(eds).NuclearOncology:DiagnosisandTherapy.LippincottWilliams&Wilkins,Philadelphia,2001.100.BallangrudAM,YangW-H,CharltonDE,McDevittMR,HamacherKA,PanageasKS,MaD,BanderNH,ScheinbergDAandSgourosG:ResponseofLNCaPspheroidsaftertreatmentwithanα-particle emitter (213Bi)-labeledanti-prostate-specificmembraneantigenantibody (J591).CancerRes2001;61:2008-2014.

Page 16: Neil Harrison Bander Curriculum Vitae Curriculum Vitae ...Neil Harrison Bander Curriculum Vitae 1 Curriculum Vitae Name: Neil Harrison Bander Place of Birth: Boston, Massachusetts

NeilHarrisonBander CurriculumVitae

16

101. Divgi CR, Oosterwijk E, Bander NH, Welt S, Larson SM, Old L: Renal Carcinoma:MonoclonalAntibodyTherapy.KhalkhaliI,MaublantJC,GoldsmithSJ(eds).NuclearOncology:DiagnosisandTherapy.LippincottWilliams&Wilkins,Philadelphia,2001.102. Uzzo RG, Kolenko V, Froelich CJ, Tannenbaum C, Molto L, Novick AC, Bander NH,BukowskiR and Finke JH: TheT cell death knell: Immune-mediate tumordeath in renal cellcarcinoma.ClinCancerRes2001;7:3276-3281.103.BelldegrunA,BanderNH,LernerSP,WoodDP,PantuckAJ:SocietyofUrologicOncologyBiotechnology Forum: New Approaches and Targets for Advanced Prostate Cancer. J Urol2001;166:1316-1321.104.McDevittMR,MaD,LaiLT,SimonJ,BorchardtP,FrankK,WuK,PellegriniV,CurcioMJ,Miederer M, Bander NH, Scheinberg, DA.: Tumor Therapy with Targeted Atomic Nano-Generators.Science2001;294:1537-1540.105. LiY,TianZ,RizviS,BanderNH,AllenBJ:Invitroandpreclinicaltargetedalphatherapyof human prostate cancer with Bi-213 labeled J591 antibody against the prostate specificmembraneantigen.ProstateCancerandProstaticDis2002;5:36-46.106.SmithJonesMP,VallabhajosulaS,NavarroV,GoldsmithSJandBanderNH: 90Y-huJ591mAb specific to PSMA: radioimmunotherapy (RIT) studies in nudemicewith prostate cancerLNCaPtumor.EurJNuclMed2002;8:951.107. ChristiansenJJ,RajasekaranSA,MoyP,ButchA,Goodglick,GuZ,ReiterR,BanderNH,RajasekaranAK:Polarityofprostatespecificmembraneantigen,prostatestemcellantigenandprostatespecificantigeninprostatetissueinaculturedepithelialcellline.TheProstate2003;55:9-19.108. Anilkumar G, Rajasekaran S, Wong S, Hankinson O, Bander NH and Rajasekaran AK:Prostate-specificmembraneantigenassociationwithfilaminAmodulatesitsinternalizationandNAALAdaseactivity.CancerRes,2003:63:2645-2648.109. Smith-JonesPM,VallabhajosulaS,NavarroV,BastidasD,GoldsmithSJandBanderNH:Radiolabeledmonoclonal antibodies specific to the extra-cellular domain of prostate-specificmembraneantigen:preclinical studies innudemicebearingLNCaPhumanprostate tumor. JNucMed,2003;44:610-617.110.NanusD,MilowskyMI,KostakogluL,Smith-JonesPM,VallabahajosulaS,GoldsmithSJandBanderNH:ClinicaluseofMonoclonalAntibodyHuJ591Therapy:TargetingProstateSpecificMembraneAntigen.JUrol,2003:170:S84-S89.111. Rajasekaran SA, Anilkumar G, Oshima E, Bowie JU, Liu H, Heston W, Bander NH,Rajasekaran AK: A novel cytoplasmic tail MXXXL motif mediates the internalization and

Page 17: Neil Harrison Bander Curriculum Vitae Curriculum Vitae ...Neil Harrison Bander Curriculum Vitae 1 Curriculum Vitae Name: Neil Harrison Bander Place of Birth: Boston, Massachusetts

NeilHarrisonBander CurriculumVitae

17

lysosomaltargetingofprostatespecificmembraneantigen.Molecular&CellBiology,2003:14:4835-4845.112. Bander,NH,TrabulsiE,KostakogluL,YaoD,VallabhajosulaS,Smith-JonesP, JoyceMA,Milowsky M, Nanus DM and Goldsmith SJ: Targeting Metastatic Prostate Cancer withRadiolabeled Monoclonal Antibody J591 in the Extracellular Domain of Prostate SpecificMembraneAntigen.JUrol,2003;170:1717-1721.113. Bander, NH, Nanus, D.M., Milowsky, M.I., Kostakoglu, L., Vallabahajosula, S., andGoldsmith,S.J.: Targetedsystemictherapyofprostatecancerwithamonoclonalantibodytoprostatespecificmembraneantigen(PSMA).SeminarsinOncology,2003;30:667-676.114. Rajasekaran SA, Anilkumar G, Oshima E, Bowie JU, Liu H, HestonW.,Bander NH, andRajasekaran AK.: A Novel Cytoplastic Tail MXXXL Motif Mediates the Internalization ofProstate-specificMembraneAntigen.MolBioCell2003;14:4835-4845.115. Vallabhajosula S, Smith-Jones PM, Navarro V, Goldsmith SJ and Bander NH:Radioimmunotherapy of prostate cancer in human xenografts using monoclonal antibodiesspecific to prostate specificmembrane antigen (PSMA): Studies in nudemice. The Prostate,2004:58:145-155.117.MilowskyM.I., Nanus D.M., Kostakoglu L., Vallabhajosula S, Goldsmith S.J., andBanderNH: Phase I Trial Results of 90Yttrium Labeled Anti-Prostate Specific Membrane AntigenMonoclonalAntibodyJ591intheTreatmentofPatientswithRecurrentProstateCancer.JClinOnc,2004;22:2522-2531.118.PatriAK,MycA,Beals,J,ThomasTP,BanderNH,BakerJR:SynthesisandinvitrotestingofJ591antibody-dendrimerconjugatesfortargetedprostatecancertherapy.BioconjugChem,2004;15:1174-1181.119. KonishiS,HamacherK,VallabhajosulaS,KothariP,BastidasD,BanderNH,GoldsmithS:Determinationof immunoreavtive fractionof radiolabeledmonoclonal antibodies:what is anappropriatemethod?CancerBiotherRadiophar2004;19:706-715.120.KellyJD,DaiJ,EschwegeP,GoldbregJS,DugganBP,WilliamsonKE,BanderNH,NanusDM:Down-regulationofBcl-2sensitisesinterferon-resistantrenalcancercellstoFas.BrJCancer2004;91:164-170.121.ChristiansenJJ,RajasekaranSA,WeimbsT,GopalakrishnaA,BanderNHandRajasekaranAK: N-glycosylation and microtubule integrity are involved in apical targeting of prostate-specificmembraneantigen:implicationsforimmunotherapy.Mol.Bio.Cell,2005;4:1-11.

Page 18: Neil Harrison Bander Curriculum Vitae Curriculum Vitae ...Neil Harrison Bander Curriculum Vitae 1 Curriculum Vitae Name: Neil Harrison Bander Place of Birth: Boston, Massachusetts

NeilHarrisonBander CurriculumVitae

18

122.BanderNH:Editorial“NovelTherapyforPSAProgressioninAbsenceofImagableDiseaseFollowingLocalTherapy.Cummings,K., (ed). ManagementofProstateCancer:AdvancesandControversies.MarcelDekker,Inc,NewYork,NY:2005.123.BanderNH,MilowskyM.I., Nanus D.M., Kostakoglu L., Vallabhajosula S, andGoldsmithS.J.: Phase I Trial Results of 177Lutetium-Labeled j591, A Monoclonal Antibody to Prostate-SpecificMembrane Antigen, in PatientsWith Androgen-Independent Prostate Cancer. J ClinOnc,2005;23:4591-4601.124.VallabhajosulaS,KujiI,HamacherKA,KonishiS,KostakogluL,KothariPA,MilowskyMI,NanusDM,BanderNHandGoldsmithSJ:PharmacokineticsandBiodistributionof111Inand177LuLabeledJ591AntibodySpecifictoProstateSpecificMembraneAntigenPredictionof90Y-J591RadiationDosimetryBasedon111Inand177Lu.JNucMed,2005;46:634-641.125.VallabhajosulaS,GoldsmithSJ,HamacherKA,KostakogluL,KonishiS,MilowskyMI,NanusDMandBanderNH: PredictionofMyelotoxicityBasedonBoneMarrowRadiationAbsorbed Dose: Radioimmunotherapy Studies using 90Y and 177Lu labeled J591 AntibodiesSpecifictoProstateSpecificMembraneAntigen(PSMA).JNucMed,2005;46:850-858.126. Vallabhajosula S,Goldsmith SJ, Kostakoglu L,MilowskyMI,NanusDMandBanderNH:Radioimmunotherapy of Prostate Cancer Using 90Y and 177Lu Labeled J591 MonoclonalAntibodies: Effect of Dose Fractionation and Multiple Treatments on Myelotoxocity. ClinCancerRes,2005;11:7195s-7200s.127. Ross JS, Gray KE,Webb I, Gray GS, RolfeM, Schenkein DP, Nanus DM,MilowskyMI,BanderNH: Antibody-BasedTherapeutics: FocusonProstateCancer. Cancer&MetastRev,2005;24:517-533.128.Bander,N.H.:Technologyinsights:monoclonalantibodyimagingofprostatecancer.NatClinPractUrol,2006:3:216-225.129.DavidKA,MilowskyMI,KostakogluL,VallabhajosulaS,GoldsmithSJ,NanusDM,BanderNH.: Clinical Utility of Radiolabeled Antibodies in Prostate Cancer. Clin Genitourin Cancer,2006;4:249-256.130. Ross JS, Gray, KE,Webb I, Gray GS, RolfeM, Schenkein DP, Nanus DM,MilowskyMI,BanderNH:PSMAandOtherCellSurfaceProteinTargetsForAntibody-BasedImmunotherapyforProstateCancer,RossJ(ed).MolecularOncolofProstateCancer.Jones&Bartlett,Boston,MA.,2006.

Page 19: Neil Harrison Bander Curriculum Vitae Curriculum Vitae ...Neil Harrison Bander Curriculum Vitae 1 Curriculum Vitae Name: Neil Harrison Bander Place of Birth: Boston, Massachusetts

NeilHarrisonBander CurriculumVitae

19

131.ChristiansenJJ,WeimbsT,BanderN,andRajasekaranAK:Differingeffectsofmicrotubuledepolymerizingandstabilizingchemotherapeuticagentsont-SNAREmediatedapicaltargetingofprostatespecificmembraneantigen.MolCancerTher,2006;5:2468-2473.132.MilowskyMI,NanusDM,KostakogluL,VallabhajosulaS,GoldsmithSJ,RossJS,andBanderNH.:VascularTargetedTherapywithAnti-PSMAMonoclonalAntibodyJ591inPatientswithAdvancedSolidTumorMalignancies.JClinOnc,2007;25:540-547.133. GoodmanOB,BarweSP,McPhersonP,VaskoA-J,Keen JH,NanusDM,BanderNH andRajasekaranAK: Interactionofprostatespecificmembraneantigenwithclathrinandadaptorproteincomplex-2.IntlJOncology,2007;31:1199-1203.134.Bander,NH.Invitededitorialcommentto:Urba,WJ,etal:TreatmentofBiochemicalRecurrenceofProstateCancerwithGranulocyte-MacrophageColony-StimulatingFactor-Secreting,Allogeneic,CellularImmunotherapy.JUrol2008,180:2017-2018.135.WangAZ,BagalkotV,VasilliouC,GuF,AlexisF,ZhangL,ShaikhM,YuetK,CimaM,LangerR,KantoffPW,BanderNH,JonS,FarokhzadOC:SuperparamagneticIronOxideNanoparticle-AptamerBioconjugatesforCombinedProstateCancerImagingandTherapy.ChemMedChem,2008,3:1311-5.136.Bander,NH.Invitededitorialcommentto:Mouraviev,V,etal,Useof111In-CapromabPendetideImmunoscintigraphytoImageLocalizedProstateCancerFociWithintheProstateGland.JUrol,2009,182:947-948.137.KurodaK,LiuH,GuoM,NavarroV,BanderNH:Docetaxeldown-regulatestheexpressionofandogenreceptorandprostate-specificantigenbutnotprostate-specificmembraneantigeninprostatecancercelllines:ImplicationsforPSASurrogacy.TheProstate,200919:1579-85.138.HaffnerMC,KronbergerIE,RossJS,SheehanCE,ZittM,MuhlmannG,OfnerD,ZelgerB,EnsingerC,YangXJ,GeleyS,MargreiterRandBanderNH:ProstateSpecificMembraneAntigenExpressionintheNeovasculatureofGastrointestinalCancers.HumPathol,2009,40:1754-61.139.BanderNH,VallabhajosulaS,GoldsmithSJ,TagawaST,NanusDM:RadioimmunotherapyofProstateCancer:TargetingProstate-SpecificMembraneAntigen.TodWSpeer(ed.).TargetedRadionuclideTherapy.LippincottWilliams&Wilkins,Philadelphia,PA,2010.140.KurodaK,LiuH,KimS,GuoM,NavarroV,BanderNH:SaporinToxin-ConjugatedMonoclonalAntibodyTargetingProstateSpecificMembraneAntigenHasPotentAnticancerActivity.TheProstate,2010,70:1286-1294.141.GleghornJP,PrattED,DenningD,LiuH,BanderNH,TagawaST,NanusDM,ParaskevaPK,andKirbyBJ.Captureofcirculatingtumorcellsfromwholebloodofprostatecancerpatients

Page 20: Neil Harrison Bander Curriculum Vitae Curriculum Vitae ...Neil Harrison Bander Curriculum Vitae 1 Curriculum Vitae Name: Neil Harrison Bander Place of Birth: Boston, Massachusetts

NeilHarrisonBander CurriculumVitae

20

usinggeometricallyenhanceddifferentialimmunocapture(GEDI)andaprostate-specificantibody.TheRoyalSocofChem,LABCHIP,2010,10:27-29.Epub20009Nov16.142.TagawaST,BeltranH,VallabhajosulaS,GoldsmithS,OsborneJ,MatulichD,Petrillo,ParmarS,SelzerJ,NanusDM,BanderNH:Anti-ProstateMembraneSpecificAntigen-basedRadioimmunotherapyforProstateCancer.Cancer,2010,116:1075-1083.143.HollandJP,DivilovV,BanderNH,Smith-JonesPM,LarsonSM,LewisJS.89Zr-DFO-J591forimmunoPETimagingofprostate-specificmembraneantigen(PSMA)expressioninvivo.JNuclMed51:1293-1300;e-publishedJuly21,2010.144.WangAZ,YuetK,ZhangL,GuFX,Huynh-LeM,Radovic-MorenoAF,KantoffPW,BanderNH,LangerRandFarokhzadOC.ChemRadnanoparticles:anovelmultifunctionalnanoparticleplatformfortargeteddeliveryofconcurrentchemoradiation.Nanomedicine,2010,5:361-368.145.Wernicke,G,EdgarMA,MoyP,LiuH,SalernoP,BanderNH,GutinPH.Prostate-SpecificMembraneAntigenasaPotentialNovelVascularTargetforTreatmentofGlioblastomaMutiforme.ArchivesofPathology&LaboratoryMedicine,2011,135:1486-1489.146.EvansMJ,Smith-JonesPM,WongvipatJ,NavarroV,KimS,BanderNH,LarsonSM,andSawyersCL.Non-invasivemeasurementsofandrogenreceptorsignalingwith64Cu-J591,apositron-emittingradiopharmaceuticalthattargetsprostate-specificmembraneantigenPNAS2011,108:9578-9582;e-publishedaheadofprintMay13,2011.PMID:21606347147.RuggieroA,HollandJP,HudolinT,ShenkerL,KoulovaA,BanderNH,LewisJS,GrimmJ: Targetingtheinternalepitopeofprostate-specificmembraneantigenwith89Zr-7E11immuno-PET.JNuclMed.2011Oct;52(10):1608-15.doi:10.2967/jnumed.111.092098.Epub2011Sep9.PMID:21908391148.NakajimaT,MitsunagaM,BanderNH,HestonWD,ChoykePL,KobayashiH.Targeted,Activatable,InVivoFluorescenceImagingofProstateSpecificMembraneAntigen(PSMA)-positiveTumorsUsingtheQuenchedHumanizedJ591Antibody-IndocyanineGreen(ICG)Conjugate.BioconjugChem,2011,22:1700-1705..E-pubJuly,2011:PMID:21740058149.DarshanMS,LoftusMS,Thadani-MuleroM,LevyBP,EscuinD,ZhouXK,GjyreziA,Chanel-VosC,ShenR,TagawaST,Bander,NH,NanusDM,andGiannakakouP.Taxane-InducedBlockadetoNuclearAccumulationoftheAndrogenReceptorPredictsClinicalResponsesinMetastaticProstateCancer.CancerRes,2011,71:6019-29.E-pub2011Jul28.PMID:21799031.150.SantanaSM,LiuH,BanderNH,GleghornJP,KirbyBJ.ImmunocaptureofProstateCancerCellsbyuseofAnti-PSMAAntibodiesinMicrodevices.BiomedMicrodevices,2011,14:401-407.E-pubDecember,2011:PMID:22143878.

Page 21: Neil Harrison Bander Curriculum Vitae Curriculum Vitae ...Neil Harrison Bander Curriculum Vitae 1 Curriculum Vitae Name: Neil Harrison Bander Place of Birth: Boston, Massachusetts

NeilHarrisonBander CurriculumVitae

21

151.HrkachJ,VonHoffD,AliM,AndrianovaE,AuerJ,CampbellT,DeWittD,FigaM,FigueiredoM,HorhotaA,LowS,McDonnellK,PeekeE,RetriarajanB,SabnisAA,SchnipperE,SongJ,SongYH,SummaJ,TompsettD,TroianoG,VanGeenHovenT,WrightJ,LoRussoP,KantoffPW,BanderNH,SweeneyC,FarokhzadOC,LangerRandZaleS.PreclinicalDevelopmentandClinicalTranslationofaPSMA-TargetedDocetaxelNanoparticlewithaDifferentiatedPharmacologicalProfile.ScienceTranslationalMedicine,2012,4:128ra39.152.HaffnerMC,LaimerJ,ChauxA,SchaferG,ObristP,BrunnerA,KronbergerIE,LaimerK,GurelB,KollerB,SeifarthC,BeierU,ZeigerB,KlockerH,RasseM,DopplerWandBanderNH.HighexpressionofPSMAinthetumor-associatedneovasculatureisassociatedwithworseprognosisinsquamouscellcarcinomaoftheoralcavity.ModernPathology,2011,1-7.153.CrowleyMJ,ScognamiglioT,LiuY-F,KleimanDA,,BeninatoT,AronovaA,LiuH,JhanwarYS,BanderNH,ZarnegarR,Elemento,OandFaheyTJIII.AnInvestigationofVascularMarkersasaPotentialTherapeuticTargetinAdrenocorticalCarcinoma.Manuscriptsubmitted.154.KirbyBJ,JodariM,LoftusMS,PrattED,Chanel-VosC,GakharG,GleghornJP,SantanaSM,LiuH,SmithJP,TagawaST,BanderNH,NanusDM,GiannakakouP,FunctionalCharacterizationofCirculatingTumorCellswithaProstate-Cancer-SpecificMicrofluidicDevice.PLoSOne,201;7(4):e35976.Epub2012Apr27.Erratumin:PLoSOne.2012;7(7):doi/10.1371/annotation/9d3d22ed-dc5a-4484-9254-1584864f4aac.PMID:22558290155.MiyamotoDT,LeeRJ,StottSL,TingDT,WitnerBS,UlmanM,SmasME,LordJB,BranniganBW,TrautweinJ,BanderNH,WuC-L,SequiatLV,SmithMR,RamaswamyS,TonerM,MaheswaranS,HaberDA.Androgenreceptorsignalingincirculatingtumorcellsasamarkerofhormonallyresponsiveprostatecancer.CancerDiscovery2:1-9.2012.PMID:23093251156.TagawaS,OsborneJandBanderNH.PSMA-basedDiagnostics.TewariA(ed).ComprehensiveTextbookofProstateCancer.Springer,NewYork,NY,2012.157.GoldsmithSJ,TagawaS,VallabhajosulaS,NilolopoulouA,LipaiI,NanusDM,BanderNH.RadioimmunotherapyofProstateCarcinoma. C.AktolunandSJGoldsmith(eds.).NuclearMedicineTherapy:PrinciplesandClinicalApplications.Springer,NewYork,NY2013.158.ValenciaPM,PridgenEM,PereaB,GaddeS,SweeneyC,KantoffPW,BanderNH,LippardSJ,LangerR,KarnikR,FarokhzadOC.SynergisticCytotoxicityofIrinotecanandCisplatininDual-DrugTargetedPolymericNanoparticles.Nanomedicine(Lond).2013May;8(5):687-98.doi:10.2217/nnm.12.134.Epub2012Oct17.PMID:23075285

159.BanderNH,CzuczmanMS,YounesA.Antibody-drugconjugatetechnologydevelopmentforhematologicdisorders.ClinAdvHematolOncol.2012Aug;10(8Suppl10):1-16.PMID:23072775

Page 22: Neil Harrison Bander Curriculum Vitae Curriculum Vitae ...Neil Harrison Bander Curriculum Vitae 1 Curriculum Vitae Name: Neil Harrison Bander Place of Birth: Boston, Massachusetts

NeilHarrisonBander CurriculumVitae

22

160.HuangC,SantanaSM,LiuH,BanderNH,HawkinsBG,KirbyBJ.Characterizationofahybriddielectrophoresisandimmunocapturemicrofluidsystemforcancercellcapture.Electrophoresis,2013Aug8.doi:10.1002/elps.201300242.[Epubaheadofprint]PMID:23925921

161.WernickeG,.GreenwoodEA,ChristosPJ,ChaoKSC,LiuH,BanderNH,ShinSJ.Prostate-

specificmembraneantigenexpressionintumor-associatedvasculatureofbreastcancers.APMIS,2013Dec5.doi:10.1111/apm.12195.[Epubaheadofprint].PMID:24304465

162.BanderNH.Antibody–DrugConjugateTargetSelection:CriticalFactors.MethodsMolBiol.2013;1045:29-40.doi:10.1007/978-1-62703-541-5_2.PMID:23913139

163. Tagawa ST, Akhtar NH, Nikolopoulou A, Kaur G, Robinson B, Kahn R, Vallabhajosula S,Goldsmith SJ, Nanus DM and Bander NH. Bone marrow recovery and subsequentchemotherapy following radiolabeled anti-prostate-specific membrane antigen (PSMA)monoclonal antibody J591 in men with metastatic castration-resistant prostate cancer.FrontiersinRadiationOncology,2013inpress.

164.HuangC,LiuH,BanderNH,KirbyBJ.Enrichmentofprostatecancercellsfrombloodcellswithahybriddielectrophoresisandimmunocapturemicrofluidicsystem.BiomedicalDevices.2013Jun27.[Epubaheadofprint]PMID:23807279

165.TagawaST,MilowskyMI,MorrisM,VallabhajosulaS,ChristosP,AkhtarNH,OsborneJ,GoldsmithSJ,LarsonS,TaskarNP,ScherHI,BanderNH,NanusDM.PhaseIIstudyofLutetium-177-labeledanti-prostate-specificmembraneantigenmonoclonalantibodyJ591formetastaticcastration-resistantprostatecancer.ClinCancerRes.2013Sep15;19(18):5182-91.doi:10.1158/1078-0432.CCR-13-0231.Epub2013May28.PMID:23714732

166.OsborneJR,GreenDA,SprattDE,LyashchenkoS,FareedySB,RobinsonBD,BeattieBJ,JainM,LewisJS,ChristosP,LarsonSM,BanderNH,ScherrDS.AProspectivePilotStudyof89Zr-J591/PSMAPositronEmissionTomography(PET)inMenwithLocalizedProstateCancerUndergoingRadicalProstatectomy.JUrol.2013Oct14.doi:pii:S0022-5347(13)05648-6.10.1016/j.juro.2013.10.041.[Epubaheadofprint]PMID:24135437

167.GakharG,NavarroV,JurishM,LeeGY,TagawaST,AkhtarNH,SeandelM,GengY,LiuH,BanderNH,GiannakakouP,ChristosPJ,KingMR,NanusDM.CirculatingTumorCellsfromProstateCancerPatientsInteractwithE-SelectinunderPhysiologicBloodFlow.PLOSONE.December27,2013.DOI:10.1371/journal.pone.0085143PMID:24386459168.Gakhar,G.,Bander,N.H.,Nanus,D.M.InvitroMethodtoObserveE-selectin-mediatedInteractionsBetweenProstateCirculatingTumorCellsDerivedFromPatientsandHumanEndothelialCells.J.Vis.Exp.2014May15(87),e51468,doi:10.3791/51468.PMID:24894373

Page 23: Neil Harrison Bander Curriculum Vitae Curriculum Vitae ...Neil Harrison Bander Curriculum Vitae 1 Curriculum Vitae Name: Neil Harrison Bander Place of Birth: Boston, Massachusetts

NeilHarrisonBander CurriculumVitae

23

169.Klute,K,Nackos,E,TasakiShinsuke,NguyenDP,BanderNH,TagawaST.Microtubuleinhibitorbasedantibody-drugconjugatesforcancertherapy.OncoTargetsTher.2014Dec3:2227-2236.PMID:25506226170.Pandit-TaskarN,O’DonoghueJA,BeylergilV,LyashchenkoS,RuanS,SolomonSB,Durack,JC,CarrasqulloJA,LefkowitzRA,GonenM,LewisJS,HollandJP,ChealSM,ReuterVE,OsborneJR,LodaaMF,Smith-JonesPM,WeberWA,BanderNH,ScherHI,MorrisMJ,LarsonSM.89Zr-huJ591immuno-PETimaginginpatientswithadvancedmetastaticprostatecancer.EurJNuclMedMolImaging.2014Nov21;41(11);2093-105.PMID:25143071171.ChakravartyD,SbonerA,NairS,GiannopoulouE,LiR,HennigS,MosqueraJM,PauwelsJ,ParkK,KossaiM,MacDonaldT,FontugneJ,ErhoN,VergaraI,GhadessiM,DavicioniE,JenkinsR,PalanisamyN,ChenZ,NakagawaS,HiroseT,BanderNH,BeltranH,FoxA,ElementoO,andRubinM.TheEstrogenreceptoralpharegulatedlncRNANEAT1isacriticalmodulatorofprostatecancer.NatureCommun2014Nov21;5:5383doi:10.1038/ncomms6383PMID:25415230172.VallabhajosulaS,NikolopoulouA,JhanwarYS,KaurG,TagawaST,NanusDM,BanderNH,GoldsmithSJ.RadioimmunotherapyofMetastaticProstateCancerwith177Lu-DOTA-huJ591AntiProstateSpecificMembraneAntigenSpecificMonoclonalAntibody. CurrRadiopharm.2015Mar13.PMID:25771365 173.Pandit-TaskarN,O'DonoghueJA,DivgiCR,WillsEA,SchwartzL,GönenM,Smith-JonesP,BanderNH,ScherHI,LarsonSM,MorrisMJ.Indium111-labeledJ591anti-PSMAantibodyforvasculartargetedimaginginprogressivesolidtumors.EJNMMIRes.2015Apr29;5:28;PMID:25984435174.Pandit-TaskarN,O'DonoghueJA,DurackJC,LyashchenkoSK,ChealSM,BeylergilV,LefkowitzRA,CarrasquilloJA,MartinezDF,FungAM,SolomonSB,GonenM,HellerG,LodaM,NanusDM,TagawaST,FeldmanJL,OsborneJ,LewisJS,ReuterV,WeberWA,BanderNH,ScherHI,LarsonSM,MorrisMJ.APhaseI/IIStudyforAnalyticValidationof89Zr-J591ImmunoPETasaMolecularImagingAgentforMetastaticProstateCancer.ClinCancerRes.2015Jul14;PubMedPMID:26175541175. Wernicke AG,Kim S, Liu H, Bander NH,Pirog EC. Prostate-Specific Membrane Antigen(PSMA) Expression in the Neovasculature ofGynecological Malignancies: Implications forPSMA-targetedTherapy. ApplImmunohistochem&MolecMorphol,2016Feb.[Epubaheadofprint]PMID:26862945 176.CrowleyMJP,ScognamiglioT,LiuY,KleimanDA,BeninatoT,AronovaA,LiuH,JhanwarYS,BanderNH,ZarnegarR,ElementoO,andFaheyTJIII.ProstateSpecificMembraneAntigenisaPotentialAnti-AngiogenicTargetinAdrenocorticalCarcinoma.JClinEndocrinolMetab.2016Mar;101(3):981-7;PMID:26771706

Page 24: Neil Harrison Bander Curriculum Vitae Curriculum Vitae ...Neil Harrison Bander Curriculum Vitae 1 Curriculum Vitae Name: Neil Harrison Bander Place of Birth: Boston, Massachusetts

NeilHarrisonBander CurriculumVitae

24

177.NguyenDP,XiongP,PanS,LiuH,GuoM,Navarro,V,KimS,BanderNH.Inductionofprostate-specificmembraneantigen(PSMA)expressionandinternalizationofanti-PSMAmonoclonalantibodiesinhumanendothelialcells,MolecularCancerResearch,2016Julypii:molcanres.0193.2016.[Epubaheadofprint]PMID:27458033. 178.McNeelDG;BanderNH;BeerTM;DrakeCG;FongL;HarrelsonS;KantoffPW;MadanRA;OhWK;Peace,DJ;PetrylakDP;PorterfieldH;SartorO;ShoreND;SlovinSF;SteinMN;ViewegJ;GulleyJ.TheSocietyforImmunotherapyofCancerConsensusStatementonTumorImmunotherapyfortheTreatmentofProstateCarcinoma.JforImmunoTherapyofCancer,underreview.

179.FungEK,ChealSM,FareedySB,PunzalanB,BeylergilV,AmirJ,ChalasaniS,WeberWA,SprattDE,VeachDR,BanderNH,LarsonSM,ZanzonicoPB,OsborneJR.TargetingofradiolabeledJ591antibodytoPSMA-expressingtumors:optimizationofimagingandtherapybasedonnon-linearcompartmentalmodeling.EJNMMIRes.2016Dec;6(1):7.doi:10.1186/s13550-016-0164-0.Epub2016Jan22.PMID:26801327

Page 25: Neil Harrison Bander Curriculum Vitae Curriculum Vitae ...Neil Harrison Bander Curriculum Vitae 1 Curriculum Vitae Name: Neil Harrison Bander Place of Birth: Boston, Massachusetts

NeilHarrisonBander CurriculumVitae

25

PATENTSISSUED(partiallist)

1. UnitedStatesPatent4,713,352(Dec.15,1987)

MonoclonalantibodypanelforearlydiagnosisandtherapyofrenalcarcinomaInventors:Bander,NeilH.;Whitmore,WilletF.;Old,LloydJ.Assignee:Sloan-KetteringInstituteforCancerResearch._________________________________________________________________________

2. UnitedStatesPatent4,935,344(Jun.19,1990)MethodforcharacterizingtypesofrenalcarcinomaandprognosisInventors: Bander; Neil H.; Cordon-Cardo, Carlos; Finstad, Connie L.; Whitmore, Willet F.;Melamed,MyronR.;Oettgen,HerbertF.,Old;LloydJ.Assignee:Sloan-KetteringInstituteforCancerResearch._________________________________________________________________________

3. UnitedStatesPatent5,145,773(Sept.8,1992)Methodtodetectsensitivitytoalpha-interferontherapyInventors:Albino,AnthonyP.;Nanus,DavidM.;Bander,NeilH.;PfefferLawrenceM..Assignee:Sloan-KetteringInstituteforCancerResearch._________________________________________________________________________

4. CanadianPatent2,261,018(July17,1997)TreatmentandDiagnosisofCancerInventor:Bander,N.H.Assignee:CornellResearchFoundation,Inc._________________________________________________________________________

5. UnitedStatesPatent5,773,292(June30,1998)Antibodies,bindingportions,andprobesrecognizinganantigenofprostateepithelialcellsbutnotantigenscirculatinginthebloodInventors:Bander,NeilH.Assignee:CornellUniversity._________________________________________________________________________

6. UnitedStatesPatent6,087,098(July11,2000)EnhancedreversetranscriptasepolymerasechainassaytodetectMNinpatientswithrenalcellcarcinomaInventors:McKiernan,JamesM.;Sawczuk,IhorS.;Buttyan,Ralph;Bander,NeilH..Assignee: The Trustees of Columbia University in the City of New York; Cornell ResearchFoundation,Inc._________________________________________________________________________

Page 26: Neil Harrison Bander Curriculum Vitae Curriculum Vitae ...Neil Harrison Bander Curriculum Vitae 1 Curriculum Vitae Name: Neil Harrison Bander Place of Birth: Boston, Massachusetts

NeilHarrisonBander CurriculumVitae

26

7. UnitedStatesPatent6,107,090(August22,2000)

TreatmentanddiagnosisofprostatecancerwithantibodiestoextracellularPSMAdomainsInventor:Bander,NeilH.Assignee:CornellResearchFoundation,Inc._______________________________________________________________________

8. UnitedStatespatent6,136,311(October24,2000)TreatmentandDiagnosisofCancer.Inventor:Bander,NeilH.Assignee:CornellResearchFoundation,Inc._________________________________________________________________________

9. AustraliaPatent733544(August30,2001)TreatmentandDiagnosisofCancerInventor:Bander,N.H.Assignee:CornellResearchFoundation,Inc._____________________________________________________________________________

10. UnitedStatespatent6,299,598(October9,2001)PostprostatectomysuprapubicdrainagecatheterInventor:Bander,NeilH.Assignee:CookUrological,Inc._________________________________________________________________________

11. NewZealandPatent333683(January1,2002)TreatmentandDiagnosisofCancerInventor:Bander,N.H.Assignee:CornellResearchFoundation,Inc._____________________________________________________________________________

12. HongKongPatentHK1062915(May30,2002)ModifiedAntibodiestoProstateSpecificMembraneAntigen(PSMA)andUsesThereofInventor:Bander,N.H.Assignee:CornellResearchFoundation,Inc.______________________________________________________________________________

13. AustralianPatent2002318169(May30,2002)ModifiedAntibodiestoProstate-specificMembraneAntigenandUsesThereofInventor:Bander,N.H.Assignee:CornellResearchFoundation,Inc_____________________________________________________________________________

Page 27: Neil Harrison Bander Curriculum Vitae Curriculum Vitae ...Neil Harrison Bander Curriculum Vitae 1 Curriculum Vitae Name: Neil Harrison Bander Place of Birth: Boston, Massachusetts

NeilHarrisonBander CurriculumVitae

27

14. UnitedStatespatent6,451,532(September17,2002)EnhancedreversetranscriptasepolymerasechainassaytodetectMNantigeninpatientswithrenalcellcarcinomaInventor:McKiernan,JamesM.;Sawczuk,IhorS.;Buttyan,Ralph;Bander,NeilH.TheTrusteesofColumbiaUniversityintheCityofNewYork;CornellResearchFoundation,Inc.______________________________________________________________________________

15. EuropeanPatentApplication2277542(May30,2002)ModifiedAntibodiestoProstate-SpecificMembraneAntigenandUsesThereofInventor:Bander,N.H.Assignee:CornellResearchFoundation,Inc._____________________________________________________________________________

16. UnitedStatespatent6,649,163(November18,2003)TreatmentandDiagnosisofCancerInventor:Bander,N.H.Assignee:CornellResearchFoundation,Inc.______________________________________________________________________________

17. UnitedStatespatent6,653,129(November25,2003)MethodsfortheIsolationofProstaticEpithelialCellsfromaBiologicalFluidInventors:Bander,N.H.,Glode,M.L.andSuh,C.I.Assignee:UniversityofColorado______________________________________________________________________________

18. EurAsiaandEasternEuropepatent004634(June24,2004)TreatmentanddiagnosisofcancerInventor:Bander,N.H.(US)Assignee:CornellResearchFoundation,Inc.

______________________________________________________________________________

19. UnitedStatespatent6,767,711(July27,2004)TreatmentanddiagnosisofprostatecancerInventor:Bander,N.H.Assignee:CornellResearchFoundation,Inc._____________________________________________________________________________

20. UnitedStatespatent6,770,450(August3,2004)TreatmentanddiagnosisofcancerInventor:Bander,N.H.

Page 28: Neil Harrison Bander Curriculum Vitae Curriculum Vitae ...Neil Harrison Bander Curriculum Vitae 1 Curriculum Vitae Name: Neil Harrison Bander Place of Birth: Boston, Massachusetts

NeilHarrisonBander CurriculumVitae

28

Assignee:CornellResearchFoundation,Inc._____________________________________________________________________________

21. Chinapatent1165764(September8,2004)

TreatmentandDiagnosisofCancerInventor:Bander,N.H.Assignee:CornellResearchFoundation,Inc._____________________________________________________________________________

22. ChinaPatentZL97197912X(September8,2004)

TreatmentandDiagnosisofProstateCancerInventor:Bander,N.H.Assignee:CornellResearchFoundation,Inc._____________________________________________________________________________

23. Israelpatent127979(February25,2005)Antibodies and Antigen Binding Portions Thereof That Bind Prostate Specific MembraneAntigen(PSMA)AndUsesThereofForDiagnosingCancerInventor:Bander,N.H.Assignee:CornellResearchFoundation,Inc.________________________________________________________________________

24. NewZealandPatent524036(July17,2005)TreatmentandDiagnosisofCancerInventor:Bander,N.H.Assignee:CornellResearchFoundation,Inc._____________________________________________________________________________

25. HongKongPatentHK1025631(July17,2005)

TreatmentandDiagnosisofCancerInventor:Bander,N.H.Assignee:CornellResearchFoundation,Inc._____________________________________________________________________________

26. UnitedStatesPatent#7,045,605(Mat16,2006)ModifiedAntibodiestoProstate-SpecificMembraneAntigenandUsesThereofInventor:Bander,N.H.etalAssignee:CornellResearchFoundation,Inc._____________________________________________________________________________

27. MexicanPatent233285(December21,2005)TreatmentandDiagnosisofCancer Inventor:Bander,N.H.

Page 29: Neil Harrison Bander Curriculum Vitae Curriculum Vitae ...Neil Harrison Bander Curriculum Vitae 1 Curriculum Vitae Name: Neil Harrison Bander Place of Birth: Boston, Massachusetts

NeilHarrisonBander CurriculumVitae

29

Assignee:CornellResearchFoundation,Inc._______________________________________________________________________

28. EuropeanPatent0956506B1(March1,2006)TreatmentandDiagnosisofCancerInventor:Bander,N.H.Assignee:CornellResearchFoundation,Inc._____________________________________________________________________________

29. AustriaPatentE319089(March1,2006)TreatmentandDiagnosisofCancerInventor:Bander,N.H.Assignee:CornellResearchFoundation,Inc._____________________________________________________________________________

30. UnitedStatesPatent7,112,412(September26,2006)TreatmentanddiagnosisofprostatecancerInventor:Bander,N.H.Assignee:CornellResearchFoundation,Inc_____________________________________________________________________________

31. UnitedStatesPatent7,163,680 (January16,2007)TreatmentanddiagnosisofprostatecancerInventor:Bander,N.H.Assignee:CornellResearchFoundation,Inc_____________________________________________________________________________

32. UnitedStatesPatent7,192,586(March20,2007)Methods and compositions for treating or preventing skin disorders using binding agentsspecificforprostateInventor:Bander,N.H.Assignee:CornellResearchFoundation,Inc_____________________________________________________________________________

33. ChinesePatentZL200410054422.3(October24,2007)Anantibodyorantigenbindingportionthereofthatbinds…Inventor:Bander,N.H.

Page 30: Neil Harrison Bander Curriculum Vitae Curriculum Vitae ...Neil Harrison Bander Curriculum Vitae 1 Curriculum Vitae Name: Neil Harrison Bander Place of Birth: Boston, Massachusetts

NeilHarrisonBander CurriculumVitae

30

Assignee:CornellResearchFoundation,Inc._____________________________________________________________________________

34. ChinesePatentZL200410054422.3(October24,2007)AnantibodyorantigenbindingportionthereofthatbindsprostatespecificmembraneantigenInventor:Bander,N.H.Assignee:CornellResearchFoundation,Inc._____________________________________________________________________________

35. MexicanPatientPA/a/2003/01084(May9,2008)ModifiedAntibodiestoProstateSpcificMembraneAntigenandUsesThereofInventor:Bander,N,.H.Assignee:CornellResearchFoundation,Inc._____________________________________________________________________________

36. UnitedStatesPatent7,514,078B2(April7,2009)MethodsoftreatingProstateCancerwithAnti-ProstateSpecificmembraneAntigensAntibodiesInventor:Bander,N.H.(USA),Carr,FrancisJ(GB),HamiltonAnita(GB)Assignee:CornellResearchFoundation,Inc._____________________________________________________________________________

37. UnitedStatesPatent7,666,414(February23,2010)ModifiedAntibodiestoProstate-SpecificmembraneAntigenandUsesThereofInventor:Bander,N.H.Assignee:CornellResearchFoundation,Inc._____________________________________________________________________________

38. UnitedStatesPatent7,666,425(February23,2010)TreatmentandDiagnosisofProstateCancerInventor:Bander,N.H.Assignee:CornellResearchFoundation,Inc._____________________________________________________________________________

39. EuropeanPatent1599228(April28,2010)ModifiedAntibodiestoProstate-SpecificMembraneAntigenandUsesThereofInventor:Bander,N.H.Assignee:CornellResearchFoundation,Inc._____________________________________________________________________________

Page 31: Neil Harrison Bander Curriculum Vitae Curriculum Vitae ...Neil Harrison Bander Curriculum Vitae 1 Curriculum Vitae Name: Neil Harrison Bander Place of Birth: Boston, Massachusetts

NeilHarrisonBander CurriculumVitae

31

40. JapanesePatent4503102(April30,2010)

TreatmentandDiagnosisofCancerInventor:BanderN.H.Assignee:CornellResearchFoundation,Inc_____________________________________________________________________________

41. JapanesePatent4619651(November5,2010)ModifiedAntibodiestoProstate-SpecificMembraneAntigenandUsesThereofInventor:Bander,N.H.etalAssignee:CornellResearchFoundation,Inc._____________________________________________________________________________

42. IsraeliPatent162230(January3,2011)Antibodies and Antigen Binding Portions Thereof That Bind Prostate Specific MembraneAntigen(PSMA)Inventor:Bander,N.H.Assignee:CornellResearchFoundation,Inc._____________________________________________________________________________

43. CanadianPatent2,447,695(July16,2014)ModifiedAntibodiestoProstate-SpecificMembraneAntigenAndUsesThereofInventor:Bander,N.H.Assignee:CornellResearchFoundation,Inc._____________________________________________________________________________

44. JapanesePatent5627191(August7,2014)Treatment and Diagnosis of Prostate Cancer with Antibodies to the Extracellular Domain ofPSMAInventor:Bander,N.H.Assignee:CornellResearchFoundation,Inc._____________________________________________________________________________

45. USPatent8,951,737(February10,2015)TreatmentandDiagnosisofCancerInventor:Bander,N.H.Assignee:CornellResearchFoundation,Inc.

Page 32: Neil Harrison Bander Curriculum Vitae Curriculum Vitae ...Neil Harrison Bander Curriculum Vitae 1 Curriculum Vitae Name: Neil Harrison Bander Place of Birth: Boston, Massachusetts

NeilHarrisonBander CurriculumVitae

32

_____________________________________________________________________________

46. IsraelPatentNo.201274ModifiedAntibodiestoProstate-SpecificMembraneAntigenandUsesThereofInventor:Bander,N.H.Assignee: CornellResearchFoundation_____________________________________________________________________________

47. JapanesePatentNo.5906090MethodsandKitsforDiagnosisofCancerandPredictionofTherapeuticValueInventor:Bander,N.H.Assignee: CornellResearchFoundation_____________________________________________________________________________

48. JapanesePatentNo.5969446 MethodsandKitsforDiagnosisofCancerandPredictionofTherapeuticValueInventor:Bander,N.H.Assignee: CornellResearchFoundation